Targeted radioligand therapy
Showing 1 - 25 of >10,000
Metastatic Castration-resistant Prostate Cancer Trial in Grand Rapids (SPECT/CT)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- SPECT/CT
-
Grand Rapids, MichiganBAMF Health
Apr 19, 2023
Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (225Ac-PSMA-R2, 68Ga-PSMA-R2)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer (mCRPC)
- 225Ac-PSMA-R2
- 68Ga-PSMA-R2
- (no location specified)
Aug 8, 2023
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in San Francisco
Active, not recruiting
- Castration Levels of Testosterone
- +6 more
- Lutetium Lu 177-PSMA-617
- Pembrolizumab
-
San Francisco, CaliforniaUniversity of California, San Francisco
Apr 11, 2022
Mechanisms of Resistance to PSMA Radioligand Therapy
Recruiting
- Prostate Cancer
- Single-photon emission computed tomography
- +2 more
-
Los Angeles, California
- +2 more
Jun 22, 2022
Carcinoid Tumor Lung, Neuroendocrine Tumor of the Lung, Carcinoma, Small-Cell Lung Trial in Iowa City (212-Lead Pentixather,
Not yet recruiting
- Carcinoid Tumor Lung
- +2 more
- 212-Lead Pentixather
- 203-Lead Pentixather SPECT/CT
-
Iowa City, IowaThe University of Iowa Theranostics Center
Sep 23, 2022
Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)
Recruiting
- Salivary Gland Cancer
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Oct 27, 2022
Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Montreal (131I-PSMA-1095 Radioligand Therapy (RLT))
Active, not recruiting
- Prostate Cancer
- +5 more
- 131I-PSMA-1095 Radioligand Therapy (RLT)
-
Montreal, Quebec, CanadaStephan Probst
Oct 24, 2022
177Lu-EB-FAPI Trial in Beijing (68Ga-FAPI for PET / CT scan and 177Lu-EB-FAPI for therapy)
Recruiting
- 177Lu-EB-FAPI
- 68Ga-FAPI for PET / CT scan and 177Lu-EB-FAPI for therapy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
May 27, 2022
Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as
Completed
- Colorectal Cancer Metastatic
- Targeted agent
- (no location specified)
Aug 31, 2023
Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Atlanta (procedure, radiation, other, drug)
Not yet recruiting
- Biochemically Recurrent Prostate Carcinoma
- Prostate Adenocarcinoma
- Biospecimen Collection
- +6 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Oct 25, 2023
Prostate Cancer Trial in Bala-Cynwyd (rhPSMA-7.3 (18F))
Not yet recruiting
- Prostate Cancer
- rhPSMA-7.3 (18F)
-
Bala-Cynwyd, PennsylvaniaMidLantic Urology
Mar 22, 2023
Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)
Recruiting
- Relapse/Refractory Multiple Myeloma
- DeepTag-GPRC5D Targeted CAR T-cells
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Oct 10, 2023
Pulmonary Hypertension Trial
Not yet recruiting
- Pulmonary Hypertension
- (no location specified)
Nov 12, 2023
Efficacy of Targeted Therapy for NSCLC
Recruiting
- Evaluation
- +2 more
- RecistTM criteria
-
Chongqing, Chongqing, ChinaCancer Center, Dapping Hospital, Army Medical Center of PLA
Nov 15, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- Image Guided Biopsy
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jun 17, 2022
Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR
Completed
- Metastatic Colorectal Adenocarcinoma
- (no location specified)
Oct 9, 2023
Nightmares, REM-Sleep Type, PTSD Trial in Geneva (Imagery Rehearsal Therapy and Targeted memory reactivation during REM sleep,
Recruiting
- Nightmares, REM-Sleep Type
- PTSD
- Imagery Rehearsal Therapy and Targeted memory reactivation during REM sleep
- Imagery Rehearsal Therapy
-
Geneva, SwitzerlandCenter for Sleep Medicine
Jul 7, 2023
Node-positive Breast Cancer Trial (Targeted axillary lymph node dissection)
Not yet recruiting
- Node-positive Breast Cancer
- Targeted axillary lymph node dissection
- (no location specified)
Jan 6, 2023
Heart Transplant Rejection Trial in Helsinki (Cell-free DNA)
Recruiting
- Heart Transplant Rejection
- Cell-free DNA
-
Helsinki, Uusimaa, FinlandHelsinki University Hospital
Oct 2, 2023
Polycystic Ovary Syndrome Trial in Hyderabad (laparoscopy / laparotomy, NO INTERVENTION)
Not yet recruiting
- Polycystic Ovary Syndrome
- laparoscopy / laparotomy
- NO INTERVENTION
-
Hyderabad, Telangana, IndiaDr. Shraddha Ramchandani
Oct 25, 2023
Metastatic Castration-resistant Prostate Cancer Trial in Oslo (212Pb-NG001)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
-
Oslo, NorwayOslo University Hospital
Feb 13, 2023
Hepatocellular Carcinoma, Chemo Effect, Chemotherapeutic Toxicity Trial in Guangzhou (Oxaliplatin,calcium folinic acid,
Recruiting
- Hepatocellular Carcinoma
- +2 more
- Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU
- +4 more
-
Guangzhou, Guangdong, ChinaSUN Yat-sen University Cancer Center
Sep 11, 2023
Prostate Cancer Trial in St Leonards, Perth (177Lu-DOTA-TLX591)
Not yet recruiting
- Prostate Cancer
- 177Lu-DOTA-TLX591
-
St Leonards, New South Wales, Australia
- +1 more
Jul 18, 2022
Prostate Cancer Stage I Trial in Torino (Katty focal therapy)
Completed
- Prostate Cancer Stage I
- Katty focal therapy
-
Torino, TO, ItalyA.O.U. San Giovanni Battista Molinette
Jan 31, 2023
Locally Advanced Unresectable Pancreatic Adenocarcinoma Trial (Padeliporfin Vascular Targeted Photodynamic (VTP) therapy)
Not yet recruiting
- Locally Advanced Unresectable Pancreatic Adenocarcinoma
- Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
- (no location specified)
Jun 25, 2023